Trial Information
Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer
Inclusion Criteria:
- Stage T1 (only)
- Over 18 years old
- Patient's consent
- Previous R0 resection of rectal tumor
Exclusion Criteria:
- Metastases (M1)
- Neoadjuvant chemotherapy or radiotherapy
- Meta- or synchronous tumors
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Recurrence rate
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Andreas Zerz, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Cantonal Hospital St. Gallen
Authority:
Switzerland: Ethikkommission
Study ID:
EKSG 05/072/2B
NCT ID:
NCT00531297
Start Date:
December 2005
Completion Date:
December 2020
Related Keywords:
- Rectal Neoplasms
- Neoplasms
- Rectal Neoplasms